MicrobiologybioRxiv
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
M. P. Ventero, O. Moreno-Perez, C. Molina-Pardines…·J. C. Rodriguez
This study identifies nasopharyngeal microbiota diversity and specific taxa as early biomarkers for reduced severity in hospitalized COVID-19 patients.
DOI 10.1016/j.jinf.2021.12.030